Sylvain Cottens as a co-founder and SVP Chemistry of Captor Therapeutics builds scientific strategy and oversees chemistry efforts.
Prior to Captor, Sylvain served as Global Head at Center for Proteomic Chemistry at Novartis Institutes for Biomedical Research, where he played key roles in multiple successful discovery and development programs, e.g. AfinitorTM and in-licensing of GilenyaTM.
Sylvain studied and received PhD in organic chemistry from EPFL Lausanne.
In his free time Sylvain enjoys cycling and travelling.